knowledge -WSS

knowledge

author：entertainment 2025-09-28 02:28:09 - browse：5

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： $1 billion proposal to grow Boston, Massachusetts biotech

WSS

Stem cell biologist probes earliest stages of human development

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

The untold story of TV’s first prescription drug ad

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

A new approach to psychiatric drug development

$1 billion proposal to grow Boston, Massachusetts biotech

leisure time

knowledge

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Microsoft's Peter Lee: Generative AI could help doctors be more human

Medicare details structure of new drug price negotiation program

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

In Memoriam: Notable people who died in 2023

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Peter Hotez and the public health issue of online harassment

Streamlined flu vaccines recommended by FDA advisory panel

23andMe had bad news about my health. I wish a person had delivered it

Immune cells and nerve overgrowth may explain recurring UTI pain

hotspot

Biden will tout long

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Lack of health data on LGBTQ+ people has serious consequences

Microsoft's Peter Lee: Generative AI could help doctors be more human

The UK government moves asylum

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

leisure time

leisure time

explore

knowledge